Publication:
Hyaluronidase in Ophthalmic Evisceration Surgery

dc.authorscopusid25723204700
dc.authorscopusid55125592200
dc.authorscopusid16245928800
dc.authorscopusid54401920900
dc.authorscopusid56393872100
dc.authorscopusid6603543240
dc.contributor.authorGül, A.
dc.contributor.authorCan, E.
dc.contributor.authorNi̇yaz, L.
dc.contributor.authorYücel, O.E.
dc.contributor.authorDuran, M.
dc.contributor.authorAritürk, N.
dc.date.accessioned2020-06-21T13:47:16Z
dc.date.available2020-06-21T13:47:16Z
dc.date.issued2015
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Gül] Adem, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Can] Ertugrul, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Ni̇yaz] Leyla, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yücel] Özlem Eşki, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Duran] Mustafa, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Aritürk] Nurşen, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractBackground: To research the effectiveness of hyaluronidase in evisceration surgery. Methods: A total of 34 patients were studied as three groups: conventional surgery group (n = 13); isotonic fluid group (n = 8); and hyaluronidase group (n = 13). Hyaluronidase and isotonic fluid were introduced into the uveo-scleral space. Intraocular content was removed, if possible by a one-scoop method, with the aid of a spoon. Results: Removing all the intraocular content as a one-scoop method was achieved in 10 of 13 (77%) in the hyaluronidase group and four of eight (50%) in the isotonic fluid group. The one-scoop method was not possible in any case without the introduction of fluid. The mean durations for the evisceration procedure were 32, 36.6 and 40.5 min in the three groups, respectively (P < 0.05). Conclusions: Using hyaluronidase in evisceration surgery greatly facilitates and speeds up the removal of all the intraocular content in ophthalmic evisceration surgery. © 2015, SAGE Publications. All rights reserved.en_US
dc.identifier.doi10.1177/0049475514562018
dc.identifier.endpage104en_US
dc.identifier.issn0049-4755
dc.identifier.issn1758-1133
dc.identifier.issue2en_US
dc.identifier.pmid25515734
dc.identifier.scopus2-s2.0-84925856637
dc.identifier.scopusqualityQ4
dc.identifier.startpage100en_US
dc.identifier.urihttps://doi.org/10.1177/0049475514562018
dc.identifier.volume45en_US
dc.identifier.wosWOS:000352003400009
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofTropical Doctoren_US
dc.relation.journalTropical Doctoren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectComplicated Eyesen_US
dc.subjectEviscerationen_US
dc.subjectHyaluronidaseen_US
dc.subjectUveal Tissue Removalen_US
dc.titleHyaluronidase in Ophthalmic Evisceration Surgeryen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files